Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05918913
Status:
AVAILABLE
Last Update Posted:
2024-06-24
First Post:
2023-06-15
Brief Title:
Expanded Access Program for Revumenib
Sponsor:
Syndax Pharmaceuticals
Organization:
Syndax Pharmaceuticals